The “Big Five” Canadian banks offer investment funds and include Royal Bank of Canada, Toronto Dominion Bank (TD Canada Trust), Bank of Nova Scotia, Bank of Montreal and Canadian Imperial Bank of Commerce (CIBC). Let’s explore the best place for you to invest.
Latest News
Taxes changes, new RRSP rules: Here’s what to watch out for in 2020 - Global News Dec 31st
Taxes changes, new RRSP rules: Here’s what to watch out for in 2020 Global NewsAre 2020's tax changes 'significant' or 'a wash'? CBC.caLower taxes, new RRSP rules and a digital-news credit among changes coming in 2020 The Globe and MailView full coverage on Google .... More »
The best GIC rates in Canada for 2024 + MORE May 24th
Investing
The best GIC rates in Canada for 2024
Find the best GIC rates in Canada. Plus, everything you need to know about how they work.
Find the best rate
Tap "Return to top" to come back here.
.... More »
The Ford government touted Therme as a 'world-class' partner for Ontario Place. In Europe, 'significant' concerns have emerged over finances Aug 16th
The warning is included in previously unreported audits. Therme says it doesn't reflect the strong financial footing of the global business..... More »
Top 100 dividend stocks in Canada 2024 + MORE Jul 30th
Overview
Top 100 Dividend Stocks
Past Performance
Methodology
Best Dividends in Canada Table of Contents
OverviewPa.... More »
The EU economy is up, volatility down and investors have figured this out + MORE Mar 25th
European stock indexes are surging ahead and the markets’ measures of volatility are running at low levels.
.... More »
Suncor, Total deal points to declining values for oil sands assets
– theglobeandmail.com
Analysts mixed on whether the Canadian firm landed a good buy, or made a questionable move considering crude prices could remain subdued for years
Number of women on Alberta corporate boards lower than national average: report
– canadianbusiness.com
EDMONTON – A report suggests the number of women who sit on corporate boards in Alberta is less than half the national average, although their presence is slowly increasing.
The study commissioned by the Alberta Securities Commission was done by the University of Calgary’s Haskayne School of Business.
It says women make up 6.6 per cent of corporate board members in the province and 8.9 per cent for companies in Alberta listed on the Toronto Stock Exchange.
An Alberta government website says women’s representation on corporate boards in Canada is 14.5 per cent. Catalyst, a non-profit group, estimates women’s share of board seats on Canadian stock index companies at 21 per cent.
Loren Falkenberg, associate dean of research, said the report aims to shed light on Alberta boardrooms in the hope the data will get corporate leaders to think differently about who they hire.
“I think there is room for more women to serve on boards,” she said Tuesday.
The data reflects the large number of energy, mining and other resource industries in Alberta…
The study commissioned by the Alberta Securities Commission was done by the University of Calgary’s Haskayne School of Business.
It says women make up 6.6 per cent of corporate board members in the province and 8.9 per cent for companies in Alberta listed on the Toronto Stock Exchange.
An Alberta government website says women’s representation on corporate boards in Canada is 14.5 per cent. Catalyst, a non-profit group, estimates women’s share of board seats on Canadian stock index companies at 21 per cent.
Loren Falkenberg, associate dean of research, said the report aims to shed light on Alberta boardrooms in the hope the data will get corporate leaders to think differently about who they hire.
“I think there is room for more women to serve on boards,” she said Tuesday.
The data reflects the large number of energy, mining and other resource industries in Alberta…
Markets took a hit on Tuesday from falling commodities prices and the widening scandal around Volkswagen’s emissions fiddle.
The Financial Post’s Jonathan Ratner looks at some of the day’s top business and financial stories.
Turing Pharmaceuticals says will cut price of drug after accused of gouging patients
– canadianbusiness.com
SAN FRANCISCO – The company that sparked an angry backlash after it raised the price of a drug for treating a deadly parasitic infection by more than 5,000 per cent says it will roll back some of the increase.
Turing Pharmaceuticals CEO Martin Shkreli told ABC News on Tuesday that the new price would make Daraprim more accessible, although he did not say what the new price for the drug would be. A spokesman for Turing did not immediately respond to a request for details.
“We’ve agreed to lower the price of Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit,” Shkreli told ABC.
The company obtained rights to sell the drug, the only U.S.-approved treatment for toxoplasmosis, in August. It hiked the price overnight from $13.50 per pill to $750.
Turing had said it would use profits to improve the drug’s formulation and develop new, better drugs for the infection. It also stressed that some patients can get financial aid from the company to obtain the drug…
Turing Pharmaceuticals CEO Martin Shkreli told ABC News on Tuesday that the new price would make Daraprim more accessible, although he did not say what the new price for the drug would be. A spokesman for Turing did not immediately respond to a request for details.
“We’ve agreed to lower the price of Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit,” Shkreli told ABC.
The company obtained rights to sell the drug, the only U.S.-approved treatment for toxoplasmosis, in August. It hiked the price overnight from $13.50 per pill to $750.
Turing had said it would use profits to improve the drug’s formulation and develop new, better drugs for the infection. It also stressed that some patients can get financial aid from the company to obtain the drug…


